Quest Diagnostics (DGX) Revenue — Quarter Ended Jun 30, 2023
Revenue for the quarter was relatively flat compared to the immediately preceding quarter, showing a modest sequential increase. However, revenue declined compared to the same quarter one year earlier.
Key takeaway
Quarter ended Jun 30, 2023 · FY2023 Q2
Revenue for the quarter was relatively flat compared to the immediately preceding quarter, showing a modest sequential increase. However, revenue declined compared to the same quarter one year earlier.
Financial snapshot
Reported revenue, sequential change, year-over-year change, and trailing four-quarter revenue.
Quarter revenue
$2.3B
Revenue reported for this quarter.
Quarter-over-quarter
+0.3%
Change from the immediately preceding quarter.
Year-over-year
-4.7%
Change from the comparable year-ago quarter.
Trailing four quarters
$9.5B
Sum of the latest four reported quarters.
Quarterly revenue trend
The latest four reported quarters with year-over-year comparisons.
| Period ended | Revenue | Year-over-year change |
|---|---|---|
| Sep 30, 2022 | $2.5B | -10.4% |
| Dec 31, 2022 | $2.3B | -15.0% |
| Mar 31, 2023 | $2.3B | -10.7% |
| Jun 30, 2023 | $2.3B | -4.7% |
Revenue performance
The reported revenue reflects a slight uptick from the prior quarter, but remains below the level achieved in the year-ago period.
Quarterly comparison
Sequentially, revenue edged higher from the preceding quarter. On an annual basis, revenue was lower than the same quarter one year earlier.
What to watch
The company’s revenue trend continues to show a decline from the year-ago level, warranting attention to underlying demand dynamics.